Dosage and administration
• adults and children 12 years and older: swallow with water 1 or 2 softgels as needed after meals and at bedtime • do not exceed 4 softgels in 24 hours except under the advice and supervision of a physician
• adults and children 12 years and older: swallow with water 1 or 2 softgels as needed after meals and at bedtime • do not exceed 4 softgels in 24 hours except under the advice and supervision of a physician
• store at controlled room temperature 20-25ºC (68-77ºF) • protect from light, heat and moisture
Simethicone 125 mg
Antigas
for the relief of
D&C yellow no. 10, FD&C blue no. 1, FD&C red no. 40, gelatin, glycerin, hypromellose, mannitol, medium-chain triglycerides, peppermint oil, propylene glycol, purified water, sorbitol, soy lecithin, titanium dioxide
1-800-452-0051
Gas-XExtra Strength Softgels offer fast, effective relief of pressure and bloating that antacids can’t provide. They are specially formulated with simethicone, the antigas medicine doctors recommend most for pressure, bloating, or discomfort referred to as gas.
READ ALL PRODUCT INFORMATION BEFORE USING.
KEEP CARTON FOR IMPORTANT INFORMATION.
Gas-XExtra Strength Softgels are concentrated to contain liquid gas-fighting medicine in a small softgels so they are easy to swallow, and there is no chalky taste.
TAMPER EVIDENT FEATURE:
Do not use if blister is broken or damaged.
1-800-452-0051
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 210299 | Gas-X Extra Strength 125 MG Oral Capsule | PSN | 15 |
| 198852 | simethicone 125 MG Oral Capsule | PSN | 15 |
| 210299 | simethicone 125 MG Oral Capsule [Gas-X] | SBD | 15 |
| 198852 | simethicone 125 MG Oral Capsule | SCD | 15 |
| 198852 | dimethicone 125 MG Oral Capsule | SY | 15 |
| 210299 | Gas-X 125 MG Oral Capsule | SY | 15 |
| 210299 | Gas-X Extra Strength 125 MG Oral Capsule | SY | 15 |
| Class | Version | Type | Effective |
|---|---|---|---|
| DIMETHICONE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0067-6275-01 | Gas-XExtra Strength Softgels | 120 in 1 CARTON | CAPSULE, LIQUID FILLED | 120 | 15 | |
| 0067-6275-10 | Gas-XExtra Strength Softgels | 1 in 1 CARTON | CAPSULE, LIQUID FILLED | 1 | 15 | |
| 0067-6275-10 | Gas-XExtra Strength Softgels | 10 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 10 | 15 | |
| 0067-6275-20 | Gas-XExtra Strength Softgels | 2 in 1 CARTON | CAPSULE, LIQUID FILLED | 2 | 15 | |
| 0067-6275-20 | Gas-XExtra Strength Softgels | 10 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 10 | 15 | |
| 0067-6275-30 | Gas-XExtra Strength Softgels | 10 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 10 | 15 | |
| 0067-6275-30 | Gas-XExtra Strength Softgels | 3 in 1 CARTON | CAPSULE, LIQUID FILLED | 3 | 15 | |
| 0067-6275-50 | Gas-XExtra Strength Softgels | 5 in 1 CARTON | CAPSULE, LIQUID FILLED | 5 | 15 | |
| 0067-6275-50 | Gas-XExtra Strength Softgels | 10 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 10 | 15 | |
| 0067-6275-72 | Gas-XExtra Strength Softgels | 6 in 1 CARTON | CAPSULE, LIQUID FILLED | 6 | 15 | |
| 0067-6275-72 | Gas-XExtra Strength Softgels | 12 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 12 | 15 | |
| 0067-6275-82 | Gas-XExtra Strength Softgels | 10 in 1 CARTON | CAPSULE, LIQUID FILLED | 10 | 15 | |
| 0067-6275-82 | Gas-XExtra Strength Softgels | 12 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 12 | 15 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0067-6275-10 | EA - Each | 0067-6275 | ccc8f669-4f90-41c1-98e4-34f7aec94da3 | 1 | 2012-07-24 |
| 0067-6275-20 | EA - Each | 0067-6275 | 220653e9-beb2-4d77-b763-d523a26130b6 | 1 | 2012-07-24 |
| 0067-6275-50 | EA - Each | 0067-6275 | 90721b79-fb28-4c10-a135-2e906776dc6c | 1 | 2012-07-24 |
| 0067-6275-72 | EA - Each | 0067-6275 | 515a89ce-10b6-4704-ab16-de6cfefaca92 | 1 | 2015-01-05 |
| 0067-6275-82 | EA - Each | 0067-6275 | 154e27b1-14f2-470e-8039-fe814791321a | 1 | 2015-01-05 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| DIMETHICONE | ACTIVE INGREDIENT | 92RU3N3Y1O | 3 | |
| DIMETHICONE | ACTIVE MOIETY | 92RU3N3Y1O | 3 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | 3 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | 3 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | 3 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | 3 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 3 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | 3 | |
| PEPPERMINT OIL | INACTIVE INGREDIENT | AV092KU4JH | 3 | |
| SORBITAN | INACTIVE INGREDIENT | 6O92ICV9RU | 3 | |
| SORBITOL | INACTIVE INGREDIENT | 506T60A25R | 3 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 3 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0067-6275 | 0067-6275-30, 0067-6275-10, 0067-6275-20, 0067-6275-50, 0067-6275-72, 0067-6275-82, 0067-6275-01 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SORBITOL | SORBITOL | 506T60A25R | TABLET, CHEWABLE / ORAL | 3555 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE / ORAL | 1488 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | SYRUP / ORAL | 120 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | SUSPENSION / ORAL | 45000 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | CONCENTRATE / ORAL | 600 mg/1ml | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, CHEWABLE / ORAL | 11.8 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | TABLET, ORALLY DISINTEGRATING / ORAL | 7 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | ELIXIR / ORAL | 833.3 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 221 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | GRANULE / ORAL | 45 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SUSPENSION / ORAL | 305 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | LIQUID / ORAL | 53460 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | SUSPENSION / ORAL | 45000 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | TABLET, ORALLY DISINTEGRATING / ORAL | 3 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | POWDER / ORAL | 36000 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SYRUP / ORAL | 250 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, DELAYED RELEASE / ORAL | 79 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | CONCENTRATE / ORAL | 0.05 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, ORALLY DISINTEGRATING / ORAL | 41 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | TABLET / ORAL | 337.28 mg | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | CAPSULE, LIQUID FILLED / ORAL | 0.08 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | ELIXIR / ORAL | 0.04 mg/1ml | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | TABLET, ORALLY DISINTEGRATING / ORAL | 3 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | SYRUP / ORAL | 4370 mg/5ml | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET / ORAL | 1127 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, ORALLY DISINTEGRATING / ORAL | 41 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, COATED / ORAL | 58 mg | ||
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, LIQUID FILLED / ORAL | 1 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, COATED PELLETS / ORAL | 3.32 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | ELIXIR / ORAL | 0.04 mg/1ml | ||
| SORBITOL | SORBITOL | 506T60A25R | POWDER / ORAL | 36000 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | TABLET, EXTENDED RELEASE / ORAL | 428 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | POWDER, FOR SUSPENSION / ORAL | 12000 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | TABLET, ORALLY DISINTEGRATING / ORAL | 7 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE / ORAL | 1488 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | GRANULE, FOR SUSPENSION / ORAL | 1.7 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, LIQUID FILLED / ORAL | 12 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | SYRUP / ORAL | 4370 mg/5ml | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | GRANULE, FOR SUSPENSION / ORAL | 1.7 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | GRANULE, FOR SUSPENSION / ORAL | 1.7 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | LIQUID / ORAL | 53460 mg | ||
| D&C YELLOW NO. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | CAPSULE, LIQUID FILLED / ORAL | 1.51 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | TABLET, COATED / ORAL | 12.96 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | SOLUTION / ORAL | 29268 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | CONCENTRATE / ORAL | 600 mg/1ml | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, EXTENDED RELEASE / ORAL | 1472 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | TABLET, ORALLY DISINTEGRATING / ORAL | 3 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | GUM, CHEWING / ORAL | 526 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | GUM, CHEWING / ORAL | 6168 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | CAPSULE / ORAL | 1111 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | GUM, CHEWING / ORAL | 6168 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | TABLET, CHEWABLE / ORAL | 3555 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | POWDER / ORAL | 36000 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | SYRUP / ORAL | 120 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 221 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, DELAYED RELEASE / ORAL | 79 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, EXTENDED RELEASE / ORAL | 1472 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gas-X Extra Strength Softgels | SIMETHICONE | Haleon US Holdings LLC | fa4a3b07-591b-4445-aa67-b17ba1e67d5c | 2025-03-14 | Warnings | 0067-6275-82 0067-6275-72 0067-6275-30 0067-6275-50 0067-6275-10 0067-6275-01 0067-6275-20 0067-6275 00067627550 00067627520 00067627582 00067627530 00067627572 00067627510 00067627501 0f32f8eb-2579-4a26-99d5-a45c50bf5bdb fa4a3b07-591b-4445-aa67-b17ba1e67d5c |
Adverse event summaries are temporarily unavailable. Other product information remains available.